Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
whether Prim-O-glucosylcimifugin can affect NO synthesis is examined in LPS-activated RAW 264
31)32)15-21(14-19)29(33
TBCA dose-dependently inhibits platelet aggregation and secretion induced by various agonists including 2-MeSADP
23(16-42)39-40-24(43)9-4-3-5-12-41-25(44)10-11-26(41)45)14-19-29(22)36(50)31-30(34(19)48)33(47)18-7-6-8-21(52-2)28(18)35(31)49/h6-8
InChiKey: KDXKERNSBIXSRK-UHFFFAOYSA-N
(R)-CPP - CAS# 126453-07-4 8921 whether Prim-O-glucosylcimifugin can affect NOProduct information CAS Number: 126453 07 4 Molecular Weight: 252. 20 Formula: C8H17N2O5P Chemical Name: (2R) 4 (3 phosphonopropyl)piperazine 2 carboxylic acid Smiles: OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1 InChiKey: CUVGUPIVTLGRGI SSDOTTSWSA N InChi: InChI=1S C8H17N2O5P c11 8(12)7 6 10(4 2 9 7)3 1 5 16(13,14)15 h7,9H,1 6H2,(H,11,12)(H2,13,14,15) t7 m1 s1 Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Shipping